Harris outlines potential solutions, from implementing nuclear-style safety regulations to focusing on narrow AI applications in specific industries
[4] "Wrong Diagnosis/Off-Label Use" Using weight loss or prediabetes codes instead of T2D
She was looking for support something real, something safe, something that would help her finally feel at home in her own body again
Comparative Cardiovascular Effectiveness of GLP-1RAs and SGLT2 Inhibitors in Type 2 Diabetes This large-scale, multinational real-world study evaluated the cardiovascular effectiveness of individual glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in over 1.2 million patients with type 2 diabetes on metformin
May 14, 2026 The NAION claims involving Ozempic, Wegovy, and other GLP-1 drugs keep getting stronger
The post says these should be established before dual therapy is even considered, and adds that age, diabetes status, and concurrent medications such as other stimulants or antihypertensives further shape the risk picture
